Fundz

Beyond Spring Inc. reported raising $7.22 Million in an initial SEC Form D filing, from an offering of $7.22 Million

PUBLIC · BYSIMar 21, 2017

Amount Raised

$7.22 Million

$7.22 Million sold, per SEC Form D (first sale Mar 21, 2017)

Round Type

Venture

Florham ParkBiotechnologyHealth CareMedicalTherapeuticsBiopharma

Quick answer

BeyondSpring raised $7.22 Million in a funding round, dated March 21, 2017. BeyondSpring is based in Florham Park, New Jersey, United States.

How much did BeyondSpring raise?
BeyondSpring raised $7.22 Million in a funding round on March 21, 2017.
What does BeyondSpring do?
BeyondSpring Inc. is a biopharmaceutical company focused on developing innovative cancer therapies.
Where is BeyondSpring based and how big is it?
BeyondSpring is based in Florham Park, New Jersey, United States.
Who are the decision-makers at BeyondSpring?
Fundz holds 2 contacts at BeyondSpring, including the VP of Finance. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as BeyondSpring that raised within 45 days of this round, from Fundz verified event records.

  • Provention Bio raised $28M on May 4, 2017.
  • BIOCEPT INC raised an undisclosed amount on April 10, 2017.
  • XTL Biopharmaceuticals Ltd raised $2.8M (Seed) on March 29, 2017.
  • CUREMARK LLC raised $3M (Seed) on March 20, 2017.
  • XTL Biopharmaceuticals Ltd raised $2.5M (Seed) on March 1, 2017.
  • Pulse Biosciences, Inc. raised $5M on February 15, 2017.

Who to call at BeyondSpring, and when

A new round usually means BeyondSpring is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BeyondSpring raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BeyondSpring, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BeyondSpring. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BeyondSpring

Location

Florham Park, New Jersey, United States

About

BeyondSpring Inc. is a biopharmaceutical company focused on developing innovative cancer therapies. The company aims to improve patient outcomes through the development of novel therapeutics. Based in Florham Park, New Jersey, BeyondSpring prioritizes research and clinical trials in oncology. They are committed to addressing unmet medical needs in cancer treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BeyondSpring raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJoy J., VP of Finance hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for BeyondSpring's next move

See what Strategic adds

BeyondSpring raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.